Acrivon Therapeutics, Inc. Common Stock
Acrivon Therapeutics, Inc. Common Stock（ACRV）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · ACRV · 截至 Jun 8, 2026
关键指标
探索 Acrivon Therapeutics, Inc. Common Stock 数据
acrv stock data · financials财务快照
完整财报分析师评级与目标价
完整预测合计: 10 · 买入占比: 90.0%
根据过去 3 个月内 10 位华尔街分析师，ACRV 共识评级为 Buy，12 个月平均目标价 $21.83 （较现价 $1.41 上涨空间 1448.23%）。
竞争对手与同行
acrv competitorsACRV
ATYR
BMEA
CBUS
IMUX
PMVP股票表现
完整历史关于 Acrivon Therapeutics, Inc. Common Stock
Acrivon Therapeutics, Inc. Common Stock Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumor…
what is acrivon therapeutics, inc. common stock · acrv stock overview · acrivon therapeutics, inc. common stock company profile · who is acrivon therapeutics, inc. common stock ceo · acrv NASDAQ · acrivon therapeutics, inc. common stock headquarters · acrivon therapeutics, inc. common stock business segments
关于股票概览与关键数据
Acrivon Therapeutics, Inc. Common Stock（ACRV）是 Biotechnology 行业的 Healthcare 类公司，于 Nov 15, 2022 在 NASDAQ 上市。截至最近交易日，ACRV 股价为 $1.41，市值约为 $44.5M。过去12个月累计回报 +10.16%，年初至今回报 -41.49%。
根据 10 位华尔街分析师，Acrivon Therapeutics, Inc. Common Stock 股票共识评级为Buy，12个月平均目标价为 $21.83。2025 财年 Acrivon Therapeutics, Inc. Common Stock 营收 —，净利润 -$77.9M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。
常见问题
截至最近一个交易日，Acrivon Therapeutics, Inc. Common Stock（ACRV）股价为 $1.41，在 NASDAQ 上市，52周区间为 $1.15 – $3.56。